// App-Quantinova.ai

2357 : Predictors of Response to Eculizumab Therapy in Paroxysmal Nocturnal Hemoglobinuria.

Researchers

Presenter

  • Donna Dorr

Principal Investigators

  • Robert A. Brodsky

Medical Centers

  • Department of Oncology, Johns Hopkins University, Baltimore, MD

  • Pediatric Oncology, Johns Hopkins University, Baltimore, MD, USA,

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Paroxysmal nocturnal hemoglobinuria

  • Rheumatoid arthritis

  • Venous thrombosis

  • Inflammatory Arthritis

  • Anemia

Biomarkers

  • Lactate dehydrogenase

Drug/Treatment

  • Eculizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved